SCHEMBL7702211

SCHEMBL7702211

CC(C)(C)OC(=O)N(CC1CCCCC1)S(C)(=O)=O

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.38
CTSS P25774 1/20 0.37
CTSK P43235 1/20 0.37
ALOX5 P09917 2/20 0.37
GAA P10253 2/20 0.35
HTR2C P28335 2/20 0.35
SLC6A4 P31645 2/20 0.35
LMNA P02545 2/20 0.34
PTGES O14684 1/20 0.33
TAS2R14 Q9NYV8 1/20 0.33
BTK Q06187 1/20 0.33
STAT3 P40763 2/20 0.33
STAT5B P51692 1/20 0.33
CRY1 Q16526 1/20 0.33
CRY2 Q49AN0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATM Q13315 1/20 0.33
KMT2A Q03164 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5711934 0.87 KDM5A (0.37) EPHX1CTSSCTSKALOX5HTR2C
SCHEMBL15800367 0.85 CHRNB2 (0.36) ALDH1A1ATMKMT2A
SCHEMBL13546948 0.84 CPN1 (0.37) EPHX1SLC6A4LMNAKMT2A
SCHEMBL9306400 0.79 ALOX5 (0.55) EPHX1CTSSCTSKALOX5GAA
SCHEMBL21574018 0.78 HTR2C (0.42) EPHX1CTSSCTSKALOX5GAA
SCHEMBL8911411 0.78 HTR2C (0.42) EPHX1CTSSCTSKALOX5GAA
SCHEMBL7329124 0.76 ALOX5 (0.43) EPHX1CTSSCTSKALOX5GAA
SCHEMBL6680983 0.76 CTSK (0.37) EPHX1CTSSCTSKALOX5GAA
SCHEMBL4780561 0.75 ALOX5 (0.39) EPHX1CTSSCTSKALOX5GAA
SCHEMBL2810316 0.74 CTSS (0.35) EPHX1CTSSCTSKALOX5HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355665-B1 ANTIHISTAMINES, ANTIALLERGENS AND IRRITABLE BOWEL SYNDROME. JAMES BLACK FOUNDATION LIMITED (GB) 2002-03-12 US disclosed
WO-1999005114-A2 1H-4(5)-SUBSTITUTED IMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS HISTAMINE H3 RECEPTOR LIGANDS JAMES BLACK FOUNDATION LIMITED (GB) 1999-02-04 WO disclosed